Digital Heart Twin to Help Treat Dangerous Heart Rhythms
By HospiMedica International staff writers Posted on 07 Jan 2025 |

Scar-dependent ventricular tachycardia (VT) is a serious and sporadic heart rhythm disturbance caused by scar tissue in the heart muscle, often resulting from a previous heart attack or genetic heart conditions. Treatment typically involves implanting a defibrillator to shock the heart back to a normal rhythm when needed or using a catheter to ablate (burn) the scar tissue that causes the abnormal rhythms. However, these treatments have significant drawbacks. Defibrillators can’t prevent the recurrence of abnormal rhythms, and repeated shocks can lead to patient discomfort, impacting their quality of life. On the other hand, identifying and treating the scarred areas in the heart can be difficult because scars can form at multiple sites, including deep within the heart, making them hard to identify. Surgeons often map the heart by inserting a catheter to detect electrical pulses that indicate abnormal areas, and sometimes they induce arrhythmias to help locate the problem. Once identified, the surgeon ablates the scar tissue, but complications and high recurrence rates are common if all affected areas are not found and treated.
Now, a new study by researchers at St George’s University of London (London, UK) introduces an innovative approach using computers to create a digital twin of the heart, which can effectively identify scar tissue deep inside the heart. This research, published in the journal Circulation, shows the potential of digital heart twins to revolutionize the treatment of scar-dependent VT, particularly in patients with a history of heart attacks or genetic conditions. The digital heart twin could serve as a non-invasive tool for locating the scarred regions responsible for abnormal rhythms, enabling cardiologists to treat these areas more efficiently and with greater precision.
In their study, the researchers tested whether digital heart twins could predict the locations of abnormal rhythms in patients with scar-dependent VT. Using advanced cardiac imaging and other data, they created computer models that replicated the hearts of 18 patients undergoing catheter ablation for this condition. The patients’ hearts were mapped using a catheter, and abnormal rhythms were induced to help locate problem areas. The digital models were then tested to see if they could predict rhythm disturbances similar to those experienced by the patients. The results showed that the digital heart twins predicted problematic areas with 41% more frequency of abnormalities compared to areas not flagged by the models, suggesting that these digital models could identify potential treatment sites without needing catheter mapping.
Moreover, the digital twins successfully predicted about 80% of the sites in patients’ hearts where electrical signals were slowed, a common sign near scar tissue. This method could reduce the likelihood of abnormal rhythms recurring and the need for additional treatments. The digital twin not only predicts current VT episodes but also forecasts potential future arrhythmias. While the effectiveness of using digital heart twins to guide catheter ablations has not yet been fully tested, the next step would involve a clinical trial comparing current VT ablation practices with a strategy guided by the digital twin from the beginning. However, implementing this procedure may be limited by the sophisticated technology required and the associated costs.
"People are now living with the consequences of heart attacks for many years, so the number of people who need procedures to treat these life-threatening abnormal heart rhythms is rising," said lead study author Dr. Michael Waight, a cardiology registrar at St George's University of London. "If digital twins were to become a reality, it could offer a safer and potentially more effective means of treatment."
The digital heart twin "gives you a road map of areas to focus on. It's an incredibly powerful advancement. It's really moving the field forward, making these procedures a lot more effective and more precise," said Dr. Dhanunjaya Lakkireddy, who was not involved in the research. "If you are able to successfully eliminate these areas that are potentially sites of ventricular tachycardias, you can reduce the time of the procedure and go precisely to the areas that are important with minimal unnecessary ablation. This could potentially improve overall morbidity and mortality with a higher success rate and result in dramatically improved patient outcomes."
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreSurgical Techniques
view channel
Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
Surgical adhesions are a frequent and often life-threatening complication following open or laparoscopic abdominal surgery. These adhesions develop in the weeks following surgery as the body heals.... Read more
Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
Leadless pacemakers marked a significant advancement in cardiac care, primarily because traditional pacemakers are dependent on leads, which are prone to breakage over time. Currently, two FDA-approved... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more